- Home
- LOAN vs SRTS Comparison
LOAN vs SRTS Comparison
Compare LOAN & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOAN | SRTS |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.2M | 44.3M |
| IPO Year | 1999 | 2016 |
Fundamental Metrics
Financial Performance| Metric | LOAN | SRTS |
|---|---|---|
| Price | $4.24 | $3.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 37.5K | 33.6K |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 10.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | $8,666,307.00 | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | $38.18 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.13 | $2.66 |
| 52 Week High | $5.79 | $5.92 |
Technical Indicators
Market Signals| Indicator | LOAN | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.91 |
| Support Level | N/A | $2.87 |
| Resistance Level | N/A | $3.11 |
| Average True Range (ATR) | 0.00 | 0.12 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 57.14 |
Price Performance
Historical ComparisonAbout LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.